| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.011 | 40.390 | 49.930 | 32.410 | 12.977 | 11.909 | 5.327 |
| Total Income - EUR | - | - | - | 1.011 | 40.390 | 69.941 | 51.646 | 13.096 | 21.327 | 6.758 |
| Total Expenses - EUR | - | - | - | 510 | 21.902 | 53.002 | 37.741 | 13.247 | 12.876 | 6.784 |
| Gross Profit/Loss - EUR | - | - | - | 501 | 18.488 | 16.939 | 13.905 | -152 | 8.451 | -27 |
| Net Profit/Loss - EUR | - | - | - | 471 | 18.125 | 16.535 | 12.952 | -483 | 7.956 | -139 |
| Employees | - | - | - | 0 | 1 | 2 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Cias Dr. Oprea S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 20 | 14.016 | 10.722 | 7.414 | 4.503 | 0 | 571 |
| Current Assets | - | - | - | 569 | 14.693 | 16.754 | 13.842 | 10.203 | 8.936 | 1.405 |
| Inventories | - | - | - | 0 | 0 | 21 | 20 | 20 | 20 | 20 |
| Receivables | - | - | - | 0 | 7.266 | 11.241 | 5.719 | 1.183 | 6.166 | 574 |
| Cash | - | - | - | 569 | 7.427 | 5.492 | 8.103 | 8.999 | 2.750 | 810 |
| Shareholders Funds | - | - | - | 514 | 18.629 | 17.030 | 13.000 | 7.935 | 8.488 | 1.667 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 75 | 10.273 | 10.579 | 8.347 | 6.904 | 451 | 326 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8810 - 8810" | |||||||||
| CAEN Financial Year |
8810
|
|||||||||
Comments - Cias Dr. Oprea S.r.l.